KWILP
AMED

Kiwi Wealth Investments Limited Partnership’s Amedisys AMED Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,437
Closed -$2.66M – 197
2022
Q1 		$2.66M Buy
+15,437
New +$2.31M 0.14% 150
2020
Q3 		– Sell
-15,563
Closed -$3.09M – 234
2020
Q2 		$3.09M Sell
15,563
-1,469
-9% -$274K 0.25% 104
2020
Q1 		$3.13M Buy
+17,032
New +$3.03M 0.31% 86
2019
Q2 		– Sell
-32,001
Closed -$3.94M – 175
2019
Q1 		$3.94M Buy
32,001
+3,895
+14% +$489K 0.36% 90
2018
Q4 		$3.29M Buy
+28,106
New +$3.31M 0.35% 88

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's AMED Position: Q2 2022 in Review

Kiwi Wealth Investments Limited Partnership sold out of Amedisys (AMED) in Q2 2022, closing a stake of 15,437 shares — an estimated $2.66M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in AMED in Q4 2018 and held it in 5 quarters. The position peaked at $3.94M in Q1 2019. 289 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Kiwi Wealth Investments Limited Partnership reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 15,437 Amedisys shares in Q2 2022, an estimated $2.66M.
  • Kiwi Wealth Investments Limited Partnership first reported a position in Amedisys in Q4 2018 and held it in 5 quarters.
  • Kiwi Wealth Investments Limited Partnership's Amedisys position peaked at $3.94M in Q1 2019.
  • 289 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q2 2022, filed 12 Aug 2022.